Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,451 | 11,355 | 24,752 | 70,857 | 78,062 |
| Marketable Securities | 31,363 | 46,520 | 41,603 | 1,173 | 1,882 |
| Receivables | 203 | 297 | 434 | 707 | 515 |
| TOTAL | $49,655 | $60,000 | $68,509 | $74,026 | $81,872 |
| Non-Current Assets | |||||
| PPE Net | 5,584 | 5,673 | 4,652 | 3,869 | 4,548 |
| Intangibles | 57,331 | 57,364 | 57,396 | 57,429 | 57,461 |
| Other Non-Current Assets | 635 | 627 | 591 | 598 | 639 |
| TOTAL | $63,550 | $63,664 | $62,639 | $61,896 | $62,648 |
| Total Assets | $113,205 | $123,664 | $131,148 | $135,922 | $144,520 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,252 | 8,608 | 9,807 | 8,684 | 8,957 |
| Other current liabilities | 11,010 | N/A | 12,364 | 15,785 | 14,886 |
| TOTAL | $17,225 | $18,981 | $22,739 | $25,091 | $24,593 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 9,421 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,574 | 2,870 | 2,267 | 1,482 | 1,792 |
| TOTAL | $26,965 | $32,747 | $30,856 | $29,332 | $34,709 |
| Total Liabilities | $44,190 | $51,728 | $53,595 | $54,423 | $59,302 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 170,174 | 170,146 | 169,976 | 169,756 | 169,727 |
| Common Shares | 441,299 | 440,280 | 439,148 | 437,151 | 435,818 |
| Retained earnings | -367,742 | -363,370 | -357,016 | -350,947 | -344,184 |
| Other shareholders' equity | -4,542 | -4,974 | -4,579 | -4,705 | -6,416 |
| TOTAL | $69,015 | $71,936 | $77,553 | $81,499 | $85,218 |
| Total Liabilities And Equity | $113,205 | $123,664 | $131,148 | $135,922 | $144,520 |